Eikon Therapeutics emerged with the promise of Nobel Prize-winning molecule tracking technology. But now, CEO Roger Perlmutter, M.D., Ph.D., and co. are using their more than $600 million war chest ...

Eikon Therapeutics is no stranger to eye-popping funding rounds, and the cancer-focused biotech has continued this trend with a $350.7 million series D to fuel its various clinical trials.

Compare Bloomberg Terminal and Refinitiv Eikon, two leading financial platforms, to understand market share, features, and ...

The upward trajectory continues for Eikon Therapeutics, which announced that it has raised $351 million to fund various cancer related clinical trials. The Series D funding unveiled Wednesday morning ...

Eikon Therapeutics, a company headed by the former Merck executive who steered the cancer drug Keytruda to FDA approval, has raised $350.7 million to support a pipeline that includes a lead drug ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Eikon Therapeutics, a well-funded drug startup run by ...

US-based biotech Eikon Therapeutics has raised $350.7m in funding to advance its portfolio of cancer candidates. The company’s lead asset, EIK1001, is a systemically administered Toll-like receptor 7 ...

The MarketWatch News Department was not involved in the creation of this content. -- Presentation highlights novel TLR7/8 co-agonist in combination with pembrolizumab and chemotherapy in late-stage ...

It may seem that the media and entertainment industry is saturated with artificial intelligence (AI). In truth, there is a lot of confusion about the technology’s use and practical benefits. AI, ...

The Series A round of funding that Eikon announced Wednesday was led by The Column Group. Roger Perlmutter, the former president of Merck Research Laboratories is the Hayward, California-based startup ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. MEMPHIS, Tenn. — Every Tuesday, as part of ...